Analyst firms · Jefferies · SMMT
Jefferies SMMT price target and rating history
Summit Therapeutics Inc. (SMMT) · Health Care
Jefferies rates Summit Therapeutics Inc. (SMMT) Buy with a $25 price target, as of its latest action on Sep 9, 2026. It has published 3 rating actions on SMMT since December 2024, including 1 upgrade and 1 downgrade. Across 5 firms with a SMMT price target in the last 12 months, the median target is $18. Jefferies's $25 is 39% above that.
- Current rating
- Buy
- Price target
- $25
- Median target, all firms
- $18
- Actions on SMMT
- 3
Jefferies price target on SMMT
Every Jefferies rating on SMMT
- Sep 9, 2026
- Mar 16, 2026
- Dec 6, 2024
How other firms rate SMMT
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Jefferies | Buy | $25 | Sep 9, 2026 |
| Bernstein | Mkt Perform | $11.90 | Aug 25, 2026 |
| Leerink Partners | Market Perform | $13 | Aug 12, 2026 |
| H.C. Wainwright | Neutral | May 22, 2026 | |
| Stifel | Buy | $45 | Apr 8, 2026 |
| Barclays | Equal Weight | $18 | Dec 17, 2025 |
| Wolfe Research | Peer Perform | Nov 18, 2025 |
Questions about Jefferies and SMMT
- What is Jefferies's price target for SMMT?
- Jefferies's latest stated price target for Summit Therapeutics Inc. (SMMT) is $25, from its action on Sep 9, 2026.
- What is Jefferies's rating on SMMT?
- Jefferies rates SMMT Buy, a bullish rating, as of Sep 9, 2026.
- When did Jefferies last change its view on SMMT?
- On Sep 9, 2026, Jefferies upgrades to Buy from Hold, price target $25.
- How does Jefferies's SMMT target compare with other analysts?
- Across 5 firms with a SMMT price target in the last 12 months, the median target is $18. Jefferies's $25 is 39% above that.
More SMMT rating histories
All Jefferies ratingsSMMT news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.